Filter
4275
Filtered Results: 4275
Text search:
reproductive
and
child
health
Featured
Recommendations
298
New Publications
1340
Language
Document type
No document type
2745
Studies & Reports
683
Guidelines
392
Manuals
138
Strategic & Response Plan
138
Fact sheets
64
Training Material
54
Situation Updates
31
Infographics
13
Brochures
7
Resource Platforms
4
Online Courses
4
Videos
2
Countries / Regions
India
200
Kenya
174
Global
149
Nepal
121
Uganda
113
Nigeria
109
Ethiopia
109
Sierra Leone
107
Tanzania
96
Malawi
91
Zambia
89
Bangladesh
84
Rwanda
78
Liberia
77
Myanmar / Burma
76
South Africa
75
Latin America and the Carribbean
65
Ghana
59
Namibia
58
Syria
53
Africa
47
Congo, Democratic Republic of
43
Philippines
42
Senegal
41
Zimbabwe
39
Haiti
37
Western and Central Europe
37
Indonesia
36
Lesotho
33
Cambodia
32
Ukraine
31
Asia
26
Mozambique
25
South–East Asia Region
24
Botswana
23
South Sudan
23
Burkina Faso
22
Yemen
21
Guinea
19
Venezuela
19
Benin
18
Pakistan
17
Cameroon
16
Afghanistan
15
Middle East and North Africa
15
East and Southern Africa
15
Eswatini/ Swaziland
15
Paraguay
13
Russia
13
Jordan
12
West and Central Africa
12
Eastern Europe
12
Somalia
12
Sudan
11
Eastern Europe and Central Asia
9
Lebanon
9
Brazil
9
Mali
8
Madagascar
8
Colombia
7
Albania
7
Western Pacific Region
7
Sri Lanka
6
Central African Republic
6
Tajikistan
5
Thailand
5
Turkey
5
Togo
5
China
5
Peru
5
Argentina
5
Papua New Guinea
5
Burundi
4
Germany
4
Spain
4
Southern Africa
4
Vietnam
4
Egypt
4
Timor Leste/ East Timor
3
Chile
3
Laos
3
Moldova
3
Palestine
3
Georgia
3
Iraq
3
Mexico
2
Iran
2
Kyrgyzstan
2
North America
2
Jamaica
2
Japan
2
France
2
Portugal
2
Côte d’Ivoire / Ivory Coast
2
Bolivia
2
Djibouti
2
Romania
2
Honduras
2
Bhutan
2
Ecuador
2
North Macedonia
1
El Salvador
1
Serbia
1
Gambia
1
Canada
1
Congo-Brazzaville
1
Niger
1
Qatar
1
Bulgaria
1
Armenia
1
USA
1
Dominican Republic
1
Croatia
1
Hungary
1
Ireland
1
Saudi Arabia
1
Turkmenistan
1
Maldives
1
United Kingdom
1
Azerbaijan
1
Bosnia and Herzegovina
1
Latvia
1
Slovakia
1
Greece
1
Poland
1
Angola
1
Chad
1
Libya
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
2046
Women & Child Health
390
Clinical Guidelines
238
Public Health
180
Key Resources
172
Capacity Building
119
Pharmacy & Technologies
17
Annual Report MEDBOX
1
Toolboxes
HIV
474
Mental Health
264
COVID-19
230
Caregiver
122
Disability
118
Conflict
113
TB
101
Planetary Health
91
Global Health Education
81
Health Financing Toolbox
71
Refugee
70
NTDs
61
Ebola & Marburg
49
Rapid Response
38
Natural Hazards
37
Pharmacy
37
Malaria
36
Zika
36
NCDs
34
AMR
26
Social Ethics
7
Polio
6
2.0 Rapid Response
4
Typhoon
3
Specific Hazards
1
Cholera
1
The United Nations Commission on Life-Saving Commodities (UNCLSC, 2012) defined 13 health products to end preventable deaths of woman and children. One of those 13 products is the neonatal resuscitator, is indispensable medical device to save newborns from asphyxia at birth. For the efficient use of...
6 July 2021. The “WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection 2021 update” is the latest document replacing the one issued in 2020. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included in the...
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ...
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List ...
Saving lives is the priority of WHO’s response in Ukraine. WHO works to ensure time-critical, lifesaving multisectoral assistance, non-discriminatory access to emergency and essential health services and priority prevention programmes, and laying the foundation for longer-term health systems recov...
Long-lasting insecticidal nets (LNs) constitute a core vector control intervention against malaria. A number of new LN products are under development and will require assessment of risks to humans. This document provides an updated generic model that can be used for the risk assessment of exposure t...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex...
This document provides a generic model that can be used for risk assessment of exposure to insecticide products applied as indoor residual sprays. It aims to harmonize the risk assessment of such insecticides for public health use in order to generate comparable data for their registering and labell...
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new class of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), and the two existing classes of tests: the tuberculin skin test (TST) and t...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
This updated version, endorsed by the World Health Assembly in May 2021 through resolution WHA74.9, reflects lessons learned in the global malaria response over the last 5 years. While the milestones and targets remain the same, the approaches to tackling the disease, in some areas, have evolved to ...
an approach to optimize the global impact of COVID-19 vaccines, based on public health goals, global and national equity, and vaccine access and coverage scenarios, first issued 20 October 2020, updated: 13 November 2020, updated: 16 July 2021, latest update: 21 January 2022
Available in English, F...
This document provides guidance for countries on how to implement activities to achieve the interruption of yaws transmission. It is intended for use by national yaws eradication programmes, partners involved in the implementation of yaws eradication activities and WHO technical staff who provide te...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
Module 9
Strategic planning
July 2017
Module 9: Strategic planning. As WHO recommends offering PrEP to people at substantial HIV risk, this module offers public health guidance for policy-makers on how to prioritize services, in order to reach those who could benefit most from PrEP, and in wh...
Measles outbreak guide
recommended
This guide also draws on the standard operating procedures (SOPs) to apply for measles outbreak response
support from the Measles & Rubella Initiative Outbreak Response Fund (17) and includes a section on
measles outbreak recovery so that contributing factors and potential root causes are identifi...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Module 10
Testing providers
July 2017
Module 10: Testing providers. This module is for people who provide testing services at PrEP sites and laboratories. It offers guidance in selecting testing services, including screening of individuals before PrEP is initiated and monitoring while they ar...
